LBO ‐02: Utility of a new HBV RNA assay in HBeAg positive and negative CHB and following HBsAg seroclearance in patients treated with ARC‐520, an RNAi drug targeting cccDNA derived HBV mRNA

Journal of Viral Hepatitis,Volume 25, Issue S2, Page 190-191, June 2018.

Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research